Health Care [ 1/12 ] | Health Care Providers & Services [ 9/73 ]
NYSE | Common Stock
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care.
In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category.
Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners.
The company also provides Labs which measures key markers over time and provides doctor-developed action plans.
Hims & Hers Health, Inc. is based in San Francisco, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 3, 25 | 0.06 Decreased by -81.25% | 0.10 Decreased by -40.00% |
| Aug 4, 25 | 0.17 Increased by +183.33% | 0.15 Increased by +13.33% |
| May 5, 25 | 0.20 Increased by +300.00% | 0.12 Increased by +66.67% |
| Feb 24, 25 | 0.11 Increased by +1.00 K% | 0.22 Decreased by -49.43% |
| Nov 4, 24 | 0.32 Increased by +900.00% | 0.04 Increased by +700.00% |
| Aug 5, 24 | 0.06 Increased by +300.00% | 0.04 Increased by +50.00% |
| May 6, 24 | 0.05 Increased by +200.00% | 0.01 Increased by +400.00% |
| Feb 26, 24 | 0.01 Increased by +120.00% | -0.02 Increased by +150.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 598.98 M Increased by +49.16% | 15.77 M Decreased by -79.13% | Increased by +2.63% Decreased by -86.01% |
| Jun 30, 25 | 544.83 M Increased by +72.61% | 42.51 M Increased by +219.66% | Increased by +7.80% Increased by +85.19% |
| Mar 31, 25 | 586.01 M Increased by +110.67% | 49.48 M Increased by +344.69% | Increased by +8.44% Increased by +111.09% |
| Dec 31, 24 | 481.14 M Increased by +95.09% | 26.02 M Increased by +1.99 K% | Increased by +5.41% Increased by +971.46% |
| Sep 30, 24 | 401.56 M Increased by +77.13% | 75.59 M Increased by +1.10 K% | Increased by +18.82% Increased by +663.94% |
| Jun 30, 24 | 315.65 M Increased by +51.82% | 13.30 M Increased by +285.79% | Increased by +4.21% Increased by +222.38% |
| Mar 31, 24 | 278.17 M Increased by +45.81% | 11.13 M Increased by +210.54% | Increased by +4.00% Increased by +175.81% |
| Dec 31, 23 | 246.62 M Increased by +47.50% | 1.25 M Increased by +111.41% | Increased by +0.50% Increased by +107.74% |